The α 2C-Del322-325 adrenoceptor polymorphism and the occurrence of left ventricular hypertrophy in hypertensives

Blood Pressure

Volumn 21, Issue 2, 2012, Pages 116-121

  Savva, Jacqueline ^a   Alfakih, Khaled ^b   Galloway, Stacey L ^a   Hall, Alistair S ^a   West, Robert M ^c   Ball, Stephen G ^a   Balmforth, Anthony J ^a   Maqbool, Azhar ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

autonomic nervous system; genetics; hypertension; hypertrophy; magnetic resonance imaging

Indexed keywords

ALPHA 2C ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; FEMALE; GENE DELETION; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 84859067882     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2011.622988     Document Type: Article

References (30)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566. (Pubitemid 20176696)
2. Lauer MS, Evans JC, Levy D. Prognostic implications of sub-clinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol. 1992;70:1180-1184.
3. Devereux RB, Pickering TG, Harshfield GA, Kleinert HD, Denby L, Clark L, et al. Left ventricular hypertrophy in patients with hypertension: Importance of blood pressure response to regularly recurring stress. Circulation. 1983; 68:470-476. (Pubitemid 13050584)
4. Kelm M, Sch äf er S, Mingers S, Heydthausen M, Vogt M, Motz W, et al. Left ventricular mass islinked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens. 1996;14:1357-1364.
5. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res. 1982;51:787-801. (Pubitemid 13217273)
6. Laks MM, Morady F, Swan HJ. Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest. 1973;64:75-78.
7. Greenwood JP, Scott EM, Stoker JB, Mary DASG. Hypertensive left ventricular hypertrophy: Relation to peripheral sympathetic drive. Am Coll Cardiol. 2001;38:1711-1717. (Pubitemid 33065459)
8. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108:560-565. (Pubitemid 36961170)
9. Brum PC, Kosek J, Patterson A, Bernstein D, Kobilka B. Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol. 2002;283:H1838-H1845. (Pubitemid 35217017)
10. Brede M, Wiesmann F, Jahns R, Hadamek K, Arnolt C, Neubauer S, et al. Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation. 2002;106: 2491-2496. (Pubitemid 35278807)
11. Small KM, Forbes SL, Rahman FF, Bridges KM, Liggett SB. A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem. 2000;275:23059-23064. (Pubitemid 30646196)
12. Bruck H, Schwerdtfeger T, Toliat M, Leineweber K, Heusch G, Philipp T, et al. Presynaptic alpha-2C adrenoceptor-mediated control of noradrenaline release in humans: Genotype-or age-dependent? Clin Pharmacol Ther. 2007;82: 525-530. (Pubitemid 47622518)
13. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 2002;347:1135-1142.
14. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging. 2003;17:323-329. (Pubitemid 36259246)
15. Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, et al. British Hypertension Society guidelines for hypertension management 1999: Summary. Br Med J. 1999;319:630-635. (Pubitemid 29414567)
16. Alfakih K, Maqbool A, Sivananthan M, Walters K, Bainbridge, G, Ridgway J, et al. Left ventricle mass index and the common, functional, X-linked angiotensin II type-2 receptor gene polymorphism (-1332 G/A) in patients with systemic hypertension. Hypertension. 2004;43:1189-1194. (Pubitemid 38691739)
17. Savva J, Maqbool A, White HL, Galloway SL, Yuldasheva NY, Ball SG, et al. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: A MERIT-HF substudy. J Card Fail. 2009;15:435-441.
18. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105:173-178. (Pubitemid 16039288)
19. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29-34. (Pubitemid 34671198)
20. Hein L, Altman JD, Kobilka BK. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature. 1999;402:181-184.
21. Neumeister A, Charney DS, Belfer I, Geraci M, Holmes C, Sharabi Y, et al. Sympathoneural and adrenomedullary functional effects of alpha2C-adrenoreceptor gene polymorphism in healthy humans. Pharmacogenet Genomics. 2005;15:143-149. (Pubitemid 40569900)
22. Metra M, Zani C, Covolo L, Nodari S, Pezzali N, Gelatti U, et al. Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: A case-control study. Eur J Heart Fail. 2006;8:131-135. (Pubitemid 43240845)
23. Canham RM, Das SR, Leonard D, Abdullah SM, Mehta SK, Chung AK, et al. Alpha2c-del322-325 and beta1-Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume. J Am Coll Cardiol. 2007;49:274-276. (Pubitemid 46054397)
24. Li JL, Canham RM, Vongpatanasin W, Leonard D, Auchus RJ, Victor RG. Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks? Hypertension. 2006;47:1140-1146. (Pubitemid 44321394)
25. Kaye DM, Smirk B, Finch S, Williams C, Esler MD. Interaction between cardiac sympathetic drive and heart rate in heart failure: Modulation by adrenergic receptor genotype. J Am Coll Cardiol. 2004;44:2008-2015. (Pubitemid 39473286)
26. Maqbool A, West RM, Galloway SL, Drinkhill MJ, Mary DA, Greenwood JP, Ball SG. Resting sympathetic nerve activity is related to age, sex and arterial pressure but not to á 2-adrenergic receptor subtype. J Hypertens. 2010;28:2084-2093.
27. Fu C, Wang H, Wang S, Shi Y, Zhou X, Sun K, et al. Association of beta 1-adrenergic receptor gene polymorphisms with left ventricular hypertrophy in human essential hypertension. Clin Biochem. 2008;41:773-778.
28. Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension. 2006;48:787-796. (Pubitemid 44610980)
29. Hogarth AJ, Mackintosh AF, Mary DASG. The effect of gender on the sympathetic nerve hyperactivity of essential hypertension. J Human Hypertens. 2007;21:239-245.
30. Schirmer H, Lunde P, Rasmussen K. Prevalence of left ventricular hypertrophy in a general population. The Troms øStudy. Eur Heart J. 1999;20:429-438. (Pubitemid 29116539)